INSITE VISION INC 4
4 · INSITE VISION INC · Filed Nov 4, 2015
Insider Transaction Report
Form 4
O'Holla Robert
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2015-11-02−30,000→ 0 totalExercise: $0.52From: 2009-09-23Exp: 2018-09-23→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02−150,000→ 0 totalExercise: $0.44From: 2012-12-14Exp: 2021-12-14→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02$0.35/sh−150,000$52,500→ 0 totalExercise: $0.32From: 2013-12-12Exp: 2022-12-12→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02$0.35/sh−150,000$52,500→ 0 totalExercise: $0.22From: 2015-12-10Exp: 2024-12-10→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02−150,000→ 0 totalExercise: $0.38From: 2010-12-16Exp: 2019-12-16→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02$0.35/sh−150,000$52,500→ 0 totalExercise: $0.33From: 2011-12-20Exp: 2020-12-20→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02$0.35/sh−150,000$52,500→ 0 totalExercise: $0.23From: 2014-12-11Exp: 2023-12-11→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]In accordance with the terms of the Agreement and Plan of Merger, dated September 15, 2015, as amended and restated, by and among Thea Acquisition Corp ("Purchaser"), Ranbaxy, Inc. and InSite Vision Incorporated ("Issuer") pursuant to which Purchaser was merged with and into Issuer (the "Merger"), this stock option was cancelled at the effective time of the Merger without consideration because the exercise price of the stock option equaled or exceeded $0.35 per share.
- [F2]This option was cancelled in connection with the Merger in exchange for a cash payment per share equal to the difference between $0.35 and the exercise price of the option.